Testosterone and erectile physiology.

Area of Science:

• Endocrinology
• Urology
• Men's Health

Background:

• Testosterone deficiency is prevalent in men over 50, contributing to sexual dysfunction, particularly erectile dysfunction (ED).
• Age-related factors like chronic illness and medications can exacerbate testosterone deficiency and ED.
• The direct causal link between hypogonadism and ED remains under investigation, though animal studies show testosterone's restorative effects.

Purpose of the Study:

• To evaluate the role of testosterone deficiency in sexual dysfunction among aging men.
• To assess the efficacy of testosterone replacement therapy (TRT) for erectile dysfunction in hypogonadal men.
• To determine the importance of adequate testosterone levels for phosphodiesterase type-5 inhibitor (PDE5i) efficacy.

Main Methods:

• Review of studies investigating testosterone's role in erectile function, including animal models and clinical trials.
• Analysis of the mechanisms by which testosterone influences erectile function (peripheral and central).
• Evaluation of TRT success rates and its impact on men with hypogonadism and ED.

Main Results:

• Testosterone replacement therapy demonstrates a 35-40% success rate in treating ED in men with hypogonadism.
• Sufficient plasma testosterone concentrations are crucial for the effectiveness of phosphodiesterase type-5 inhibitors.
• Testosterone gels are a preferred formulation for supplementation, offering significant benefits to some men with ED.

Conclusions:

• Testosterone replacement therapy is an effective treatment for erectile dysfunction in men with confirmed hypogonadism.
• Maintaining adequate testosterone levels is essential for optimizing ED treatment outcomes, including with PDE5 inhibitors.
• Testosterone supplementation, particularly via gels, can be highly beneficial for a subset of men experiencing ED.